Studies are proposed to examine the impact of opioids on the development of T cells using murine models of T cell differentiation. These studies are significant because of the need to understand those factors which control the maintenance of mature T cells in individuals who abuse opioid drugs. It is well established that the thymus is a primary site of HIV infection and the infection appears to involve both T cells and dendritic cells in the thymus. The infection appears to lead to reduced CD4+ cells in the thymus and this may be due to either direct or indirect killing mechanisms mediated by the HIV. Recent studies have established that the infection of the thymus with HIV leads to a subsequent reduction in the production of mature and functional CD4+ cells in the periphery. Factors which result in reduced levels of replacement CD4+ cells are clearly critical for the preservation of the immune system in the AIDS patient. The failure of the immune system to produce adequate replacement of CD4+ cells contributes significantly to the degeneration of the immune response in the late stages of AIDS. Several studies using experimental animal models have shown that the administration of opioids results in a reduction in the number of thymocytes, and in particular a reduction of cells at the critical CD4+CD8+CD3+ intermediate stage of differentiation. The mechanism of this effect is not well understood, and because of the common use of opioid drugs in the AIDS patient, it is important to understand the impact of the opioids on the development of T cells. We propose to carry out studies to address three specific aims. First, we wish to determine the relationship between T cell differentiation and the expression of the mu-, kappa-, delta-opioid receptors. Second, we wish to assess the impact of opioid administration on the differentiation of T cells in the thymus. And finally, we wish to determine the effect of opioid administration on the functional capacity of the developing T cells in the thymus. It is hoped that these studies will provide valuable information relating to the control of the T cell arm of the immune system in opioid abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011130-04
Application #
6175482
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Sharp, Charles
Project Start
1997-09-29
Project End
2002-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
4
Fiscal Year
2000
Total Cost
$195,651
Indirect Cost
Name
Temple University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Chen, Xiaohong; Geller, Ellen B; Rogers, Thomas J et al. (2007) Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend 88:36-41
Chen, Xiaohong; Geller, Ellen B; Rogers, Thomas J et al. (2007) The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats. Brain Res 1153:52-7
Dimitrova, Dessislava I; Reichenbach, Nancy L; Yang, Xiaowei et al. (2007) Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B). AIDS Res Hum Retroviruses 23:123-34
Sun, Ronghua; Iribarren, Pablo; Zhang, Ning et al. (2004) Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol 173:428-36
Zhang, Ning; Rogers, Thomas J; Caterina, Michael et al. (2004) Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol 173:594-9
McCarthy, Lois E; Nitsche, Joshua F; Pintar, John E et al. (2004) The delta-opioid receptor participates in T-cell development by promoting negative selection. J Neuroimmunol 153:91-8
Lieu, Yen K; Kumar, Atul; Pajerowski, Anthony G et al. (2004) Requirement of c-myb in T cell development and in mature T cell function. Proc Natl Acad Sci U S A 101:14853-8
Zhang, Ning; Hodge, Dave; Rogers, Thomas J et al. (2003) Ca2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J Biol Chem 278:12729-36
Szabo, Imre; Wetzel, Michele A; Zhang, Ning et al. (2003) Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol 74:1074-82
Rogers, Thomas J; Peterson, Phillip K (2003) Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 24:116-21

Showing the most recent 10 out of 28 publications